% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hasoon:285740,
author = {Hasoon, Jahfer and Hamilton, Calum A and Firbank, Michael
and Schumacher, Julia and Colloby, Sean J and Donaghy, Paul
C and Taylor, John-Paul and Thomas, Alan J},
title = {{M}ultimodal biomarkers to predict dementia-free survival
and cognitive decline in mild cognitive impairment with
{L}ewy bodies.},
journal = {Parkinsonism $\&$ related disorders},
volume = {145},
issn = {1353-8020},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DZNE-2026-00297},
pages = {108265},
year = {2026},
abstract = {Predicting conversion to dementia in mild cognitive
impairment with Lewy bodies (MCI-LB) remains challenging.
Furthermore, there is limited research combining predictive
markers in MCI-LB. We explored the utility of Lewy body and
Alzheimer's disease biomarkers for the prediction of future
decline in MCI-LB.Eighty-seven participants were included
(35 MCI-AD, 15 possible MCI-LB, 37 probable MCI-LB).
Baseline assessment involved MRI, EEG, bloods and cognitive
testing. Follow up was completed yearly with review of
diagnosis and repeat cognitive testing. We evaluated the
relationship between baseline biomarkers and dementia-free
survival time. We also investigated biomarker effects on
future cognitive decline using annualised change in ACE-R.
The value of combining biomarkers with baseline cognitive
test score was assessed using forward selection.In probable
MCI-LB, shorter dementia-free survival time was strongly
associated with smaller hippocampal volume (hazard ratio =
2.36, $95\%$ CI 1.41 - 3.94) and smaller posterior cortical
volume (hazard ratio = 2.62, $95\%$ CI 1.35 - 5.10). Reduced
EEG dominant frequency, increased relative delta and theta
power, reduced insula volume, increased plasma tau, and
increased plasma GFAP were also associated with an increased
hazard ratio. Posterior atrophy, hippocampal atrophy, and
GFAP were significant predictors of ACE-R decline. Combining
blood and MRI biomarkers improved model quality for
dementia-free survival (GFAP and hippocampal atrophy) and
cognitive test decline (AB ratio and posterior
atrophy).Blood, EEG and MRI biomarkers of dementia with Lewy
bodies, neurodegeneration and Alzheimer's co-pathology
demonstrate utility for prognosis in MCI-LB. Combining
biomarkers across modalities improves prognostic accuracy.},
keywords = {Dementia with lewy bodies (Other) / Disease progression
(Other) / EEG (Other) / MRI (Other) / Mild cognitive
impairment (Other) / Plasma biomarkers (Other)},
cin = {AG Storch},
ddc = {610},
cid = {I:(DE-2719)5000014},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41780490},
doi = {10.1016/j.parkreldis.2026.108265},
url = {https://pub.dzne.de/record/285740},
}